Data / Form D filings / EXICURE, INC.
EXICURE, INC.: Form D filings
EXICURE, INC., a biotechnology company in Skokie, IL, filed 4 Form D notices with the SEC between 2017 and 2018. The latest, on August 31, 2018, reports $22 million sold of a $22 million offering to 39 investors.
Find out what EXICURE, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8045 LAMON AVE, SUITE 410, Skokie, IL, 60077
- Phone
- (847) 673-1700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2017
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1698530
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2018 | New notice | $22,001,477 | $22,001,477 | $0 | 39 | Aug 22, 2018 | sec.gov |
| Oct 10, 2017 | New notice | $52,572,575 | $20,791,609 | $31,780,966 | 119 | Sep 26, 2017 | sec.gov |
| Oct 10, 2017 | New notice | $43,090,544 | $43,090,544 | $0 | 84 | Sep 26, 2017 | sec.gov |
| Jul 3, 2017 | New notice | $6,250 | $6,250 | $0 | 4 | Jun 16, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| C. Shad Thaxton | Director | |
| Matthias R. Schroff | Executive Officer | |
| Jay R. Venkatesan | Director | |
| David S. Snyder | Executive Officer | |
| Chad Mirkin | Director | |
| David R. Walt | Director | |
| Ekambar R. Kandimalla | Executive Officer | |
| Helen S. Kim | Director | |
| David A. Giljohann | Executive Officer, Director |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Aug 27, 2018 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EXICURE, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.